Business Description
Level Biotechnology Inc
NAICS : 325412
SIC : 2834
ISIN : TW0003118006
Description
Level Biotechnology Inc is a Taiwan based company engages in the provision of biotechnological services. It offers cell culture, immune protein, gene nucleic acids, and molecular biology, and instruments and equipment. It offers preclinical trial services in the areas of mammalian toxicology, genetic toxicology, pharmacology, biocompatibility, and model animal production.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 34.62 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.14 | |||||
| Interest Coverage | 204.2 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.14 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.6 | |||||
| 3-Year EBITDA Growth Rate | 1.7 | |||||
| 3-Year EPS without NRI Growth Rate | 2.8 | |||||
| 3-Year FCF Growth Rate | -8.2 | |||||
| 3-Year Book Growth Rate | 1.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.83 | |||||
| 9-Day RSI | 74.45 | |||||
| 14-Day RSI | 74.12 | |||||
| 6-1 Month Momentum % | 3.5 | |||||
| 12-1 Month Momentum % | -1.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.69 | |||||
| Quick Ratio | 2.34 | |||||
| Cash Ratio | 1.85 | |||||
| Days Inventory | 72.34 | |||||
| Days Sales Outstanding | 63.13 | |||||
| Days Payable | 44.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.07 | |||||
| Dividend Payout Ratio | 0.88 | |||||
| 3-Year Dividend Growth Rate | 9.4 | |||||
| Forward Dividend Yield % | 5.07 | |||||
| 5-Year Yield-on-Cost % | 6.35 | |||||
| Shareholder Yield % | 5.32 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.23 | |||||
| Operating Margin % | 10.26 | |||||
| Net Margin % | 9.52 | |||||
| FCF Margin % | 9.47 | |||||
| ROE % | 11.65 | |||||
| ROA % | 7.71 | |||||
| ROIC % | 17.92 | |||||
| ROC (Joel Greenblatt) % | 72.23 | |||||
| ROCE % | 14.2 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.23 | |||||
| PE Ratio without NRI | 17.23 | |||||
| Shiller PE Ratio | 14.16 | |||||
| Price-to-Owner-Earnings | 16.74 | |||||
| PEG Ratio | 2.27 | |||||
| PS Ratio | 1.64 | |||||
| PB Ratio | 1.96 | |||||
| Price-to-Tangible-Book | 1.96 | |||||
| Price-to-Free-Cash-Flow | 17.4 | |||||
| Price-to-Operating-Cash-Flow | 15.49 | |||||
| EV-to-EBIT | 7.91 | |||||
| EV-to-EBITDA | 6.34 | |||||
| EV-to-Revenue | 0.94 | |||||
| EV-to-FCF | 9.45 | |||||
| Price-to-Projected-FCF | 0.87 | |||||
| Price-to-Median-PS-Value | 0.98 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.4 | |||||
| Price-to-Graham-Number | 1.23 | |||||
| Price-to-Net-Current-Asset-Value | 2.65 | |||||
| Price-to-Net-Cash | 5.56 | |||||
| Earnings Yield (Greenblatt) % | 12.63 | |||||
| FCF Yield % | 5.78 | |||||
| Forward Rate of Return (Yacktman) % | 16.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Level Biotechnology Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 660.611 | ||
| EPS (TTM) (NT$) | 1.93 | ||
| Beta | 0.27 | ||
| Volatility % | 10.56 | ||
| 14-Day RSI | 74.12 | ||
| 14-Day ATR (NT$) | 0.494918 | ||
| 20-Day SMA (NT$) | 32.09 | ||
| 12-1 Month Momentum % | -1.9 | ||
| 52-Week Range (NT$) | 29.2 - 34.5 | ||
| Shares Outstanding (Mil) | 32.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Level Biotechnology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Level Biotechnology Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Level Biotechnology Inc Frequently Asked Questions
What is Level Biotechnology Inc(ROCO:3118)'s stock price today?
The current price of ROCO:3118 is NT$33.25. The 52 week high of ROCO:3118 is NT$34.50 and 52 week low is NT$29.20.
When is next earnings date of Level Biotechnology Inc(ROCO:3118)?
The next earnings date of Level Biotechnology Inc(ROCO:3118) is .
Does Level Biotechnology Inc(ROCO:3118) pay dividends? If so, how much?
The Dividend Yield %  of Level Biotechnology Inc(ROCO:3118) is 5.07% (As of Today), Highest Dividend Payout Ratio of Level Biotechnology Inc(ROCO:3118) was 1.5. The lowest was 0.69. And the median was 0.85. The  Forward Dividend Yield % of Level Biotechnology Inc(ROCO:3118) is 5.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers